{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:08:43Z","timestamp":1768036123802,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["USB1-31147-XX-13"],"award-info":[{"award-number":["USB1-31147-XX-13"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW009574"],"award-info":[{"award-number":["D43TW009574"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3116-7","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T12:18:18Z","timestamp":1525263498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-5311","authenticated-orcid":false,"given":"Andrea","family":"DeLuca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri","family":"Dhumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar","family":"Paradkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Suryavanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Mave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rewa","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shri Vijay Bala Yogendra","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidula","family":"Hulyolkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Nangude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Pardeshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileep","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"3116_CR1","unstructured":"Union Budget 2017 - 18. Budget Speech by Hon\u2019ble Finance Minister [\n                    http:\/\/indiabudget.nic.in\/ub2017-18\/bs\/bs.pdf\n                    \n                  ]."},{"key":"3116_CR2","unstructured":"Program RNTC: National Strategic Plan for tuberculosis elimination 2017\u20132025. In. New Delhi, India: Central TB Division; 2017."},{"issue":"6","key":"3116_CR3","first-page":"935","volume":"95","author":"GW Comstock","year":"1967","unstructured":"Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967;95(6):935\u201343.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"3116_CR4","first-page":"827","volume":"119","author":"GW Comstock","year":"1979","unstructured":"Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119(5):827\u201330.","journal-title":"Am Rev Respir Dis"},{"issue":"9899","key":"3116_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(13)61131-9","volume":"382","author":"H Ayles","year":"2013","unstructured":"Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, Shanaube K, Chishinga N, Bond V, Dunbar R, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet. 2013;382(9899):1183\u201394.","journal-title":"Lancet"},{"issue":"10010","key":"3116_CR6","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","volume":"386","author":"MX Rangaka","year":"2015","unstructured":"Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386(10010):2344\u201353.","journal-title":"Lancet"},{"issue":"10010","key":"3116_CR7","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/S0140-6736(15)00401-8","volume":"386","author":"P Das","year":"2015","unstructured":"Das P, Horton R. Tuberculosis\u2014getting to zero. Lancet. 2015;386(10010):2231\u20132.","journal-title":"Lancet"},{"key":"3116_CR8","volume-title":"Global tuberculosis report 2016","year":"2016","unstructured":"Organization WH, editor. Global tuberculosis report 2016. Geneva: Organization WH; 2016."},{"issue":"2","key":"3116_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000326","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, Bhaumik S, Bhuyan SS. India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality. BMJ Glob Health. 2016;2(2):e000326.","journal-title":"BMJ Glob Health"},{"issue":"10075","key":"3116_CR10","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(17)30790-0","volume":"389","author":"M Pai","year":"2017","unstructured":"Pai M, Correa N, Mistry N, Jha P. Reducing global tuberculosis deaths-time for India to step up. Lancet (London, England). 2017;389(10075):1174\u20136.","journal-title":"Lancet (London, England)"},{"issue":"9777","key":"3116_CR11","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","volume":"377","author":"T Samandari","year":"2011","unstructured":"Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588\u201398.","journal-title":"Lancet"},{"issue":"11","key":"3116_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/QAD.0b013e32832d53fc","volume":"23","author":"JE Golub","year":"2009","unstructured":"Golub JE, Chaisson RE, Martinson NA. Additive effects of isoniazid preventive therapy and HAART. AIDS. 2009;23(11):1446\u20137.","journal-title":"AIDS"},{"key":"3116_CR13","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of World Health Organization 1982, 60."},{"issue":"12","key":"3116_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM199709183371201","volume":"337","author":"CC Whalen","year":"1997","unstructured":"Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University research collaboration. N Engl J Med. 1997;337(12):801\u20138.","journal-title":"N Engl J Med"},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2334-14-91","volume":"14","author":"J Ayieko","year":"2014","unstructured":"Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"3116_CR16","first-page":"1507","volume":"13","author":"VV Banu Rekha","year":"2009","unstructured":"Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India's revised tuberculosis control Programme: a situational analysis. Int J Tuberc Lung Dis. 2009;13(12):1507\u201312.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"3116_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036001","volume":"7","author":"MT Pho","year":"2012","unstructured":"Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012;7(4):e36001.","journal-title":"PLoS One"},{"issue":"2","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5588\/ijtld.12.0415","volume":"17","author":"B Rekha","year":"2013","unstructured":"Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"3116_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047400","volume":"7","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, et al. Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PLoS One. 2012;7(12):e47400.","journal-title":"PLoS One"},{"issue":"1","key":"3116_CR20","first-page":"41","volume":"43","author":"R Narain","year":"1970","unstructured":"Narain R, Mayurnath S, Rao MS, Murthy SS. Feasibility of a chemoprophylaxis trial in India against tuberculosis. A pilot study. Bull World Health Organ. 1970;43(1):41\u201352.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"3116_CR21","first-page":"274","volume":"63","author":"AR Singh","year":"2017","unstructured":"Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, Verma M, Nagar M, Kumar AM. Isoniazid preventive therapy among children living with tuberculosis patients: is it working? A mixed-method study from Bhopal, India. J Trop Pediatr. 2017;63(4):274\u201385.","journal-title":"J Trop Pediatr"},{"issue":"8","key":"3116_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5588\/ijtld.14.0072","volume":"18","author":"HR Shivaramakrishna","year":"2014","unstructured":"Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, Kumar AM, Moonan PK. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis. 2014;18(8):919\u201324.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3116_CR23","first-page":"1","volume-title":"National Guidelines on diagnosis and treatment of Pediatric Tuberculosis, Revised National Tuberculosis Control Programme","author":"Central TB Devision MoHaFW, Goverment of India","year":"2012","unstructured":"Central TB Devision MoHaFW, Goverment of India. National Guidelines on diagnosis and treatment of Pediatric Tuberculosis, Revised National Tuberculosis Control Programme; 2012. p. 1\u201316."},{"issue":"2","key":"3116_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010542","volume":"6","author":"A Gupte","year":"2016","unstructured":"Gupte A, Padmapriyadarsini C, Mave V, Kadam D, Suryavanshi N, Shivakumar SV, Kohli R, Gupte N, Thiruvengadam K, Kagal A, et al. Cohort for tuberculosis research by the indo-US medical partnership (CTRIUMPH): protocol for a multicentric prospective observational study. BMJ Open. 2016;6(2):e010542.","journal-title":"BMJ Open"},{"key":"3116_CR25","unstructured":"Sinhal K: Soon, ban on blood tests to detect TB. In: Times of India. 2012."},{"key":"3116_CR26","unstructured":"Improving Treatment Completion for Latent Tubeculosis Infeciton Among Health Care Workers [\n                    https:\/\/stacks.cdc.gov\/view\/cdc\/5237\/cdc_5237_DS1.pdf\n                    \n                  ]."},{"key":"3116_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1756-0500-6-342","volume":"6","author":"K Butcher","year":"2013","unstructured":"Butcher K, Biggs BA, Leder K, Lemoh C, O'Brien D, Marshall C. Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients. BMC Res Notes. 2013;6:342.","journal-title":"BMC Res Notes"},{"issue":"11","key":"3116_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5588\/ijtld.16.0920","volume":"21","author":"V Bond","year":"2017","unstructured":"Bond V, Floyd S, Fenty J, Schaap A, Godfrey-Faussett P, Claassens M, Shanaube K, Ayles H, Hargreaves JR. Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR). Int J Tuberc Lung Dis. 2017;21(11):49\u201359.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"3116_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5588\/ijtld.16.0914","volume":"21","author":"C Miller","year":"2017","unstructured":"Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E. It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es salaam, Tanzania. Int J Tuberc Lung Dis. 2017;21(11):42\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"3116_CR30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/522312","volume":"45","author":"A Mathew","year":"2007","unstructured":"Mathew A, Takalkar A. Living with tuberculosis: the myths and the stigma from the Indian perspective. CID. 2007;45(9):1247.","journal-title":"CID"},{"issue":"11","key":"3116_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5588\/ijtld.16.0788","volume":"21","author":"N Sommerland","year":"2017","unstructured":"Sommerland N, Wouters E, Mitchell EMH, Ngicho M, Redwood L, Masquillier C, van Hoorn R, van den Hof S, Van Rie A. Evidence-based interventions to reduce tuberculosis stigma: a systematic review. Int J Tuberc Lung Dis. 2017;21(11):81\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"3116_CR32","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/09540121.2017.1283390","volume":"29","author":"KB Jacobson","year":"2017","unstructured":"Jacobson KB, Niccolai L, Mtungwa N, Moll AP, Shenoi SV. \u201cIt\u2019s about my life\u201d: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017;29(7):936\u201342.","journal-title":"AIDS Care"},{"issue":"11","key":"3116_CR33","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.5588\/ijtld.13.0315","volume":"17","author":"S Zaeh","year":"2013","unstructured":"Zaeh S, Kempker R, Stenehjem E, Blumberg HM, Temesgen O, Ofotokun I, Tenna A. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis. 2013;17(11):1396\u2013401.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"3116_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/pha.13.0010","volume":"3","author":"D Skinner","year":"2013","unstructured":"Skinner D, Hesseling AC, Francis C, Mandalakas AM. It\u2019s hard work, but it's worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3(3):191\u20138.","journal-title":"Public Health Action"},{"issue":"1","key":"3116_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-5-7","volume":"5","author":"ME Rutherford","year":"2012","unstructured":"Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, Alisjahbana B, Hill PC. Adherence to isoniazid preventive therapy in Indonesian children: a quantitative and qualitative investigation. BMC Research Notes. 2012;5(1):1\u20137.","journal-title":"BMC Research Notes"},{"issue":"11","key":"3116_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.5588\/ijtld.15.0015","volume":"19","author":"V Cox","year":"2015","unstructured":"Cox V, de Azevedo V, Stinson K, Wilkinson L, Rangaka M, Boyles TH. Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting. Int J Tuberc Lung Dis. 2015;19(11):1300\u20134.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3116_CR37","first-page":"Cd006591","volume":"5","author":"JM M'Imunya","year":"2012","unstructured":"M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev. 2012;5:Cd006591.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3116-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:29:07Z","timestamp":1589455747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3116-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3116-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"17 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by BJGMC Clinical Trials Unit ethics review committee and the Johns Hopkins IRB. The Johns Hopkins Medicine IRB and the BJGMC Clinical Trials Unit IRB approved a verbal consent process, as the study involved minimal risk. All participants were verbally consented and agreed to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"202"}}